BCR-ABL tyrosine kinase inhibitors

APO IMA 100 Pill - orange round, 9mm

Pill with imprint APO IMA 100 is Orange, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Apotex Corp.

Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Acute Lymphoblastic Leukemia; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Imatinib (Imatinib [ im-ma-ta-nib ])-APO IMA 100-100 mg-Orange-Round
Imatinib (Imatinib [ im-ma-ta-nib ])-APO IMA 100-100 mg-Orange-Round
Imatinib (Imatinib [ im-ma-ta-nib ])-APO IMA 100-100 mg-Orange-Round

Imatinib
Generic Name: imatinib [ im-ma-ta-nib ]
Imprint: APO IMA 100
Strength: 100 mg
Color: Orange
Size: 9.00 mm
Shape: Round
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Silicon dioxide, Crospovidone, Magnesium stearate, Hypromellose 2910 (5 mPa.s), Ferric oxide red, Ferric oxide yellow, Polyethylene glycol 8000,
Latest News
Related Drugs